Skip to main content

Navigation group

Type at least 3 characters
2,749 articles

Articles

Original Research

Published on 04 Oct 2022

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination

in Vaccines and Molecular Therapeutics

  • Somruedee Chatsiricharoenkul
  • Suvimol Niyomnaitham
  • Harry Joshua Posen
  • Zheng Quan Toh
  • Paul V. Licciardi
  • Patimaporn Wongprompitak
  • Thaneeya Duangchinda
  • Pattarakul Pakchotanon
  • Warangkana Chantima
  • Kulkanya Chokephaibulkit
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
Frontiers in Immunology
doi 10.3389/fimmu.2022.1010835
  • 3,096 views
  • 8 citations